Overall OPGN gets a technical rating of 0 out of 10. OPGN scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The short term trend is neutral, while the long term trend is still negative. We need to see a little more continued positive action to make this really interesting.
80% of all other stocks performed better in the past year than OPGN.
OPGN is currently trading near the lower end of its 52 week range, which is not a good sign. OPGN is lagging the S&P500 Index which is trading in the middle of its 52 week range.
In the last month OPGN has a been trading in the 1.87 - 3.10 range, which is quite wide. It is currently trading near the lows of this range.
Prices have been falling strongly lately, it is better to avoid new long positions here.
Volume is considerably higher in the last couple of days. In combination with the strong move down this is a bad signal.
Warning: OPGN has an average volume of 19040 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
OPGN is an average performer in the Biotechnology industry, it outperforms 62% of 568 stocks in the same industry.